跳至主要内容
临床试验/NCT02686398
NCT02686398已完成4 期

Immunogenicity of a Trivalent Influenza Vaccine in Patients With Chronic Kidney Disease Undergoing Hemodialysis: MF59-adjuvanted Versus Non-adjuvanted Vaccines

Korea University Guro Hospital0 个研究点目标入组 174 人开始时间: 2013年10月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
174
主要终点
Seroprotection rate (A/H1N1, A/H3N2, B)

研究概览

简要总结

During the 2013-2014 influenza season, CKD patients undergoing HD participated in the study. The patients were randomized into two groups (MF59-adjuvanted vaccine group or non-adjuvanted vaccine group) and were immunized with the respective vaccine. Sera were collected prior to vaccination and at 1and 6 months post vaccination. Levels of hemagglutination inhibition (HI) antibodies were measured.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Chronic kidney disease patients undergoing hemodialysis
  • Who have given written informed consent at the time of enrollment

排除标准

  • Recipients of influenza vaccine of 2013-2014 season before the study
  • History of egg allergy

结局指标

主要结局

Seroprotection rate (A/H1N1, A/H3N2, B)

时间窗: 1 month after vaccination

the proportion of participants with a HI titer level of ≥1:40

Seroconversion rate (A/H1N1, A/H3N2, B)

时间窗: Change of titer from pre-vaccination to 1 month after vaccination

the percentage of subjects with either a pre-vaccination HI titer ≥1:10 and a ≥4-fold increase in 1 month after vaccination HI antibody titer from pre-vaccination or pre-vaccination HI titer \<1:10 and a 1 month after vaccination HI titer of ≥1:40

GMT fold change (A/H1N1, A/H3N2, B)

时间窗: Change of GMT from pre-vaccination to 1 month after vaccination

GMT ratio of the 1 month after vaccination titer to pre-vaccination titer

次要结局

  • Seroprotection rate (A/H1N1, A/H3N2, B)(6 months after vaccination)
  • Seroconversion rate (A/H1N1, A/H3N2, B)(Change of titer from pre-vaccination to 6 months after vaccination)
  • GMT fold change (A/H1N1, A/H3N2, B)(Change of GMT from pre-vaccination to 6 months after vaccination)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hee Jin Cheong

MD, PhD

Korea University Guro Hospital

相似试验

Immunogenicity of a Trivalent Influenza Vaccine in... | 临床试验